期刊文献+

载脂蛋白E基因多态性与子痫前期的相关性 被引量:1

Correlation Between Gene Polymorphism of Apolipoprotein E and Preeclampsia
原文传递
导出
摘要 目的探讨载脂蛋白E(ApoE)基因多态性与血脂水平、子痫前期(PE)发生的相关性。方法选取2007年1月至10月于广州医学院附属深圳沙井医院(深圳市宝安区沙井人民医院)住院分娩的孕产妇120例为研究对象,年龄为20~35岁。将其中诊断为PE者纳入PE组(n=50),其余正常妊娠孕妇纳入对照组(n=70)(本研究遵循的程序符合本院人体试验委员会制定的伦理学标准,得到该委员会批准,分组征得受试者的知情同意,并与其签订临床研究知情同意书)。两组孕妇的平均年龄及体重指数(BMI)比较,差异无统计学意义(P>0.05)。应用聚合酶链反应-限制性内切酶片段长度多态性(PCR-RFLP)检测受试者ApoE基因型及其血脂[总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL)-C、高密度脂蛋白(HDL)-C]水平,并进行统计学分析。结果 PE组孕妇血清TC,TG与LDL-C水平明显高于对照组,而HDL-C水平低于对照组,两组比较,差异均有统计学意义(P<0.05);PE组孕妇携带ApoEε3/4基因型者明显高于对照组,两组比较,差异有统计学意义(P<0.05);PE组孕妇携带ApoEε3/4基因型者脂代谢异常程度高于其他基因型。结论 ApoE基因多态性与PE孕妇存在脂代谢异常有关,可能为PE孕妇发病的遗传因素之一。 Objective To study the correlation of apolipoprotein E (ApoE) gene polymorphism, lipid levels and preeelampsia (PE). Methods From January to October 2007, a total of 120 pregnant women, at the age of 20-35, were recruited into this study. Among them, 50 cases who were diagnosed as PE were included into PE group (n= 50), the rest normal pregnant women were included into control group (n= 70). The study protocol was approved by the Ethical Review Board of Investigation in Human Being of Shenzhen Shajing Affiliated Hospital of Guangzhou Medical College. Informed consent was obtained from each participate. There had no significant differences of average age and body mass index (BMI) between two groups (P〉0. 05). The polymerase chain reaction-restriction enzyme fragment length polymorphism (PCR-RFLP) was used to analyze the ApoE genotypes. The lipid levels, including total cholesterol (TC), triglyeride (TG), low density lipoprotein (LDL)-C, high density lipoprotein (HDL)-C were analyzed. Results The levels of serum TC, TG and LDL-C in PE group were significantly higher than those in control group (P〈0.05), however, the levels of HDL-C in PE group were much lower than those in control group (P〈0.05). The ApoE ε3/4 genotype frequency in PE group was significantly higher than that in control group (P 〈0. 05); Metabolic disorders were more serious in PE group with ApoE ε3/4 than other genotypes. Conclusions ApoE gene polymorphism was related to the abnormal lipid metabolism in PE patients, and may be a genetic one of factors of PE pathogenesis.
出处 《中华妇幼临床医学杂志(电子版)》 CAS 2012年第3期258-261,共4页 Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition)
关键词 子痫前期 脂代谢 载脂蛋白E 基因多态性 preeclampsia lipid metabolism apolipoprotein E gene polymorphism
  • 相关文献

参考文献10

  • 1Sandra H, McGladdery SH, Jiri J, et al. Lipoprotein lipase and ApoE polymorphisms.. Relationship to hypertriglyceridemia during pregnancy[J]. J LipidRes, 2001, 42(11): 1905-1912.
  • 2Wenham PR, Price WH, Blundell G, et al. Apolipoprotein E genotyping by one-stage PCR [J]. Lancet, 1991, 337 (8750) : 1158-1159.
  • 3Malinova M, Paskaleva V. Oxidative stress in preeclampsia[J]. Akush Ginekol (Sofiia), 2004, 43(Suppl): 24-26.
  • 4Akihiko W, Nobuo I, Yuji O, et al. Lipoprotein particles in preeelampsia: Susceptibility to oxidative modifieation[J]. Obstet Gynecol, 2000, 96: 55.
  • 5王伽略,杨孜,王荣,李智,李惠娟,曾琳.子痫前期患者血脂代谢调节的探讨[J].现代妇产科进展,2006,15(6):438-441. 被引量:13
  • 6Lin SK, Kao JT, Tsai SM, et al. Association of apolipoprotein E genotypes with serum lipid profiles in a healthy population of Taiwan[J]. Ann Clin Lab Sei, 2004, 34(4): 443-448.
  • 7Nakashima Y, Plump AS, Raines EW, etal. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree[J]. Arterioscle Thromb, 1994, 14(6): 133-140.
  • 8Boord J, Maeda K, Makowski L, et al. ApoE polymorphism in severe hypereholesterolemia[J]. Arterioseler Thromb Vase Biol, 2002, 22(10): 1686-1691.
  • 9Jeffrey SC, Michel T, Rami B, et al. Effect of atorvastatin on plasma ApoE metabolism in patients with combined hyperlipidemia[J]. Lipid Res, 2002, 43: 1464.
  • 10Arruda RM, Peotta VA, Meyrelles SS, et al. Evaluation of vascular function in apolipoprotein E knockout mice with angiotensin-dependent renovascular hypertension[J ]. Hypertension, 2005, 46(4): 932-936.

二级参考文献15

  • 1Llurba E,Casals E,Dominguez C,et al.Atherogenic lipoprotein subfraction profile in preeclamptic women with and without high triglycerides:different pathophysiologic subsets in preeclampsia[J].Metabolism,2005,54:1504-1509
  • 2Bayhan G,Kocyigit Y,Atamer A,et al.Potential atherogenic roles of lipids,lipoprotein(a) and lipid peroxidation in preeclampsia[J].Gynecol Endocrinol,2005,21:1-6
  • 3Sattar N,Bendomir A,Berry C,et al.Lipoprotein subfraction concentrations in preeclampsia:pathogenic parallels to atherosclerosis[J].Obstet Gynecol,1997,89:403-408
  • 4Daniel A,Enquobahrie,Michelle A,et al.Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia[J].Am J Hypertens,2004,17:574-581
  • 5Cunningham FC,Gant NF,Leveno KJ,et al.Williams Obstetrics[M].21st ed.Mc Graw-Hill Companies Inc,2001.569-570
  • 6Satter N,Austin MA,Scott MG,et al.Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in preeclampsia[J].Br J Obstet Gynaecol,1996,103:614-620
  • 7WakatsukiA,Ikenoue N,Yujiokatani,et al.Lipoprotein particles in preeclampsia:susceptibility to oxidative modification[J].Obstet Gynecol,2000,96:55-59
  • 8Watanabe S,Tagawa T,Yamakawa K,et al.Inhibition of the renin-angiotensin system prevents free fatty acid-induced acute endothelial dysfunction in humans[J].Arterioscler Thromb Vasc Biol,2005,25:2376-2380
  • 9Steinberg HO,Paradisi G,Hook G,et al.Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production[J].Diabetes,2000,49:1231-1239
  • 10Kim F,Tysseling KA,Rice J,et al.Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKbeta[J].Arterioscler Thromb Vasc Biol,2005,25:989-994

共引文献12

同被引文献16

  • 1谢幸,苟文丽.妇产科学.8版[M].北京:人民卫生出版社,2013:58.
  • 2Ramsay JE, Jamieson N, Greer IA, et al. Paradoxical elevafion in adiponectin concentrations in women with preeclampsia[J]. Hypertension, 2003 ,42 (5) : 891-894.
  • 3Scioscia M, Gumaa K, Rademacher TW. The link between insulin resistance and preeclampsia: new perspectives[J]. J Reprod Immunol,2009,82(2): ioo-ios.
  • 4Xu A, Wang Y , Xu JY ,et al. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome[J]. Clin Chern, 2006, 52( 3) : 405-413.
  • 5Boord JB, Maeda K, Makowski L, et al. Combined adipocytemacrophage fatty acid-binding protein deficiency improves metabolism, arteriosclerosis, and survival in apolipoprotein E-deficient mice[J]. Circulation, 2004,11 O( II ) : 1192-1498.
  • 6Cabre A, Lazaro I, Girona J , et al. Fatty acid binding protein 1 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients[J]. Atherosclerosis, 2007,195 ( 1): eI50-eI58.
  • 7Cabre A, Lazaro I, Girona J, et al. Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidernia in diabetes[n. J Lipid Res,2008,49(8): 1746-1751.
  • 8Rhee EJ, Lee Wy, Park CY, et al. The association of serum adipocyte fatty acid-binding protein with coronary artery disease in Korean adults[J]. Eur J Endocrinol,2009, 160(2): 165-172.
  • 9Fasshauer M, Seeger J, Waldeyer T, et al . Serum levels of the adipokine adipocyte fatty acid-binding protein arc increased In preeclampsia[J]. Am J Hypert ens , 2008, 21( 5) : 582-586.
  • 10Sahu S,Abraham R, Veda valli R,et aL. Study of lipid profile, lipid peroxidation and vitamin E in pregnancy induced hypc r tensionl]]. Indian J Physiol Pharmacol,2009,53(4) :365-369.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部